Figures & data
Table 1 Plants frequentlya used in herbal products submitted for market authorization in Tanzania (2009–2020) (N = 84)
Fig. 3 Number of multicomponent product applications with the number of herbal substances/plants in the products
![Fig. 3 Number of multicomponent product applications with the number of herbal substances/plants in the products](/cms/asset/a3f9025e-f272-4e25-a69a-443bda5985ee/jppp_a_12370212_f0003.jpg)
Table 2 Frequency of preclinical toxicity studies in herbal medicine dossiers submitted in Tanzania (2009–2020)
Table 3 Safety data submitted for ten frequently used plants in the herbal products applications (2009–2020)
Table 4 Safety data submitted in herbal products applications with herbal components with documented risks of adverse reactions or toxicity (2009–2020)
Table 5 Quality parameters with safety implications tested in herbal substances submitted for marketing authorization (2009–2020)
Table 6 Quality parameters with safety implications tested in finished herbal medicines submitted for marketing authorization (2009–2020)
Table 7 Safety data declared in package inserts of herbal medicines submitted for marketing authorization (2009–2020)
Table 8 Side effects declared in the registered herbal medicines package inserts or summary of product characteristics (2009–2020)
jppp_a_12370212_sm0001.docx
Download MS Word (15.8 KB)jppp_a_12370212_sm0002.docx
Download MS Word (17.2 KB)Availability of data and materials
The data are not available due to privacy and confidentiality.